Uwe Liebchen
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotic Use and Resistance 6
- Pharmacology 30
- Antibiotics Pharmacokinetics and Efficacy 30
- Co-authors
- Christina ScharfMichael PaalMichael ZöllerInes SchroederMichael IrlbeckMartin G. KeesAlexander KratzerFrieder Kees
In The Last Decade
Uwe Liebchen
46 papers receiving 748 citations
Peers
Comparison fields: 5 of 82
- Applied Microbiology and Biotechnology 105
- Molecular Medicine 124
- Pharmacology 407
- Analytical Chemistry 88
- Critical Care and Intensive Care Medicine 43
Countries citing papers authored by Uwe Liebchen
This map shows the geographic impact of Uwe Liebchen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uwe Liebchen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uwe Liebchen more than expected).
Fields of papers citing papers by Uwe Liebchen
This network shows the impact of papers produced by Uwe Liebchen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uwe Liebchen. The network helps show where Uwe Liebchen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Uwe Liebchen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 5 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 12 | |
| 11 | 2023 | 7 | |
| 12 | 2023 | 4 | |
| 13 | 2022 | 0 | |
| 14 | 2022 | 22 | |
| 15 | 2022 | 9 | |
| 16 | 2021 | 3 | |
| 17 | 2021 | 70 | |
| 18 | 2021 | 4 | |
| 19 | 2019 | 13 | |
| 20 | 2014 | 24 |
About Uwe Liebchen
Uwe Liebchen is a scholar working on Applied Microbiology and Biotechnology, Pharmacology, Molecular Medicine, Epidemiology and Infectious Diseases, having authored 51 papers that have together received 760 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (30 papers), Pneumonia and Respiratory Infections (14 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Antibiotic Use and Resistance (6 papers), Antibiotic Resistance in Bacteria (6 papers), Sepsis Diagnosis and Treatment (6 papers), Antifungal resistance and susceptibility (5 papers) and Neonatal Health and Biochemistry (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (105 citations), Molecular Medicine (124 citations), Pharmacology (407 citations), Analytical Chemistry (88 citations) and Critical Care and Intensive Care Medicine (43 citations). Uwe Liebchen has collaborated with scholars based in Germany, Austria and Canada. Frequent co-authors include Christina Scharf, Michael Paal, Michael Zöller, Ines Schroeder, Michael Irlbeck, Martin G. Kees, Alexander Kratzer, Frieder Kees, Michael Vogeser and Bernd Salzberger. Their work appears in journals such as Antibiotics, Antimicrobial Agents and Chemotherapy, Scientific Reports, Annals of Intensive Care and Journal of Critical Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.